Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3. (Q42914090)
Jump to navigation
Jump to search
scientific article published on 7 September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3. |
scientific article published on 7 September 2010 |
Statements
1 reference
Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3. (English)
1 reference
1 reference
1 reference
Dongsheng Tu
1 reference
Kayu Chin
1 reference
Olga Ludkovski
1 reference
Wendy Parulekar
1 reference
Malcolm J Moore
1 reference
7 September 2010
1 reference
Identifiers
1 reference